The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Botulinum toxin in clinical practice
Open accessAbstract
Botulinum toxin, the most potent biological toxin, has become a powerful therapeutic tool for a growing number of clinical applications. This review draws attention to new findings about the mechanism of action of botulinum toxin and briefly reviews some of its most frequent uses, focusing on evidence based data. Double blind, placebo controlled studies, as well as open label clinical trials, provide evidence that, when appropriate targets and doses are selected, botulinum toxin temporarily ameliorates disorders associated with excessive muscle contraction or autonomic dysfunction. When injected not more often than every three months, the risk of blocking antibodies is slight. Long term experience with this agent suggests that it is an effective and safe treatment not only for approved indications but also for an increasing number of off-label indications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Arnon, S. S., Schechter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Hauer, J., Layton, M., et al. (2001) · JAMA · doi:10.1001/jama.285.8.1059 · Cited by 1,814
Neurotoxins Affecting Neuroexocytosis
Schiavo, G., Matteoli, M., & Montecucco, C. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.2.717 · Cited by 1,269
de Paiva, A., Meunier, F. A., Molgó, J., Aoki, K. R., & Dolly, J. O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3200 · Cited by 673
Brashear, A., Gordon, M. F., Elovic, E. P., Kassicieh, V. D., Marciniak, C. M., Do, M., Lee, C.-H., JENKINS, S. W., & Turkel, C. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011892 · Cited by 565
Intrasphincteric Botulinum Toxin for the Treatment of Achalasia
Pasricha, P. J., Ravich, W. J., Hendrix, T. R., Sostre, S., Jones, B., & Kalloo, A. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321203 · Cited by 556
Botulinum A toxin for cranial‐cervical dystonia: A double‐blind, placebo‐controlled study
Jankovic, J., & Orman, J. (1987) · Neurology · doi:10.1212/wnl.37.4.616 · Cited by 553
Self-citationJankovic, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010032 · Cited by 447
Self-citationSafety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia
Brin, M. F., Lew, M. F., Adler, C. H., Comella, C. L., Factor, S. A., Jankovic, J., O’Brien, C., Murray, J. J., Wallace, J. D., Willmer–Hulme, A., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1431 · Cited by 437
Self-citationRecommendations for the use of botulinum toxin type A in the management of cerebral palsy
Graham, H. K., Aoki, K. R., Autti-Rämö, I., Boyd, R. N., Delgado, M. R., Gaebler-Spira, D. J., Gormley, M. E., Guyer, B. M., Heinen, F., Holton, A. F., et al. (2000) · Gait & Posture · doi:10.1016/s0966-6362(99)00054-5 · Cited by 399
Brisinda, G., Maria, G., Bentivoglio, A. R., Cassetta, E., Gui, D., & Albanese, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410201 · Cited by 379
Cited by
Jankovic, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70574-9 · Cited by 332
Self-citationThermoregulatory and thermal control in the human cutaneous circulation
Kellogg, D. L. (2010) · Frontiers in Bioscience · doi:10.2741/s105 · Cited by 137
Metadata
- Authors
- Jankovic, J.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2004-07-01
- Volume
- 75
- Issue
- 7
- Pages
- 951-957
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2129974957
- Cited by
- 408
- References
- 46
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Botulinum toxin in clinical practice. https://app.cochat.ai/papers/10.1136/jnnp.2003.034702
- The paper
- Jankovic, J. (2004). Botulinum toxin in clinical practice. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2003.034702
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.